Molecular Partners AG (MOLN) États Financiers et Données Historiques

Molecular Partners AG (MOLN) — Prix $3.92 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Molecular Partners AG (MOLN): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Marges des 12 derniers mois: marge brute 0.0%, marge opérationnelle 0.0%, marge nette 0.0%.

Au prix actuel de $3.92, MOLN affiche des résultats négatifs (PER non significatif) et un ROE de -67.67%. La capitalisation boursière s'établit à $147M.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus$23.0M$20.0M$10.4M$20.4M$9.3M$9.3M$189.6M$7.0M$5.0M0
Coût des Ventes$14.6M$17.8M$15.6M$43.5M$56.1M$55.7M$50.7M$47.8M$47.5M$2.0M
Marge Brute$8.5M$2.2M-$5.2M-$23.1M-$46.7M-$46.4M$138.8M-$40.8M-$42.5M-$2.0M
R&D$35.2M$37.5M$38.2M$43.5M$56.1M$55.7M$50.7M$48.8M$48.6M$40.2M
Frais Généraux$7.2M$8.3M$9.5M$13.2M$11.0M$16.9M$21.8M$19.0M$17.2M$14.9M
Charges Opérationnelles$42.5M$45.9M$47.8M$57.0M$67.7M$72.7M$72.9M$20.3M$18.7M$50.9M
Résultat Opérationnel-$19.5M-$25.8M-$37.4M-$36.7M-$58.3M-$63.4M$116.6M-$61.1M-$61.2M-$58.1M
EBITDA-$17.5M-$24.7M-$36.1M-$33.7M-$59.6M-$60.7M$119.0M-$59.5M-$51.6M-$59.5M
Charges d'Intérêt$89000$197000$102000$100625$323881$608137$648123$49000$25000$18000
Résultat Avant Impôts-$18.6M-$25.4M-$37.0M-$36.3M-$62.8M-$63.8M$117.9M-$62.0M-$54.0M-$61.6M
Impôts0-$1000-$156000$17000-$11000$200000$2000$2000
Résultat Net-$18.6M-$25.4M-$37.0M-$36.3M-$62.8M-$63.8M$117.9M-$62.0M-$54.0M-$61.7M
BPA$-0.91$-1.22$-1.75$-1.69$-2.51$-2.06$3.63$-1.89$-1.59$-1.65
BPA Dilué$-0.91$-1.22$-1.75$-1.69$-2.51$-2.06$3.54$-1.89$-1.59$-1.65
Actions en Circulation (Diluées)$20.4M$20.9M$21.2M$21.4M$25.0M$31.0M$33.3M$32.8M$34.0M$37.3M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus0000
Marge Brute-$658569-$641873-$9.4M-$482103
Résultat Opérationnel-$14.9M-$15.8M-$13.4M-$13.5M
EBITDA-$14.2M-$15.2M-$12.6M-$13.1M
Résultat Net-$14.8M-$15.8M-$13.1M-$13.5M
BPA$-0.32$-0.33$-0.35$-0.35
BPA Dilué$-0.32$-0.33$-0.35$-0.35

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$149.7M$131.3M$99.0M$75.7M$133.7M$71.8M$87.9M$67.3M$63.9M$82.7M
Placements à Court Terme$30.5M$9.7M0$19.4M$40.0M$61.0M$161.2M$119.6M$85.6M$10.4M
Créances$844000$1.2M$51.6M$2.5M$2.8M$25.7M$1.7M$3.1M$286000$1.9M
Stocks0-$9.4M-$2.3M-$486000-$19900000000
Actifs Courants$181.6M$142.5M$153.3M$99.9M$177.8M$164.2M$254.8M$192.5M$154.3M$96.9M
Immobilisations Corporelles$2.5M$1.9M$1.5M$4.2M$9.4M$8.1M$7.2M$5.7M$4.2M$5.2M
Goodwill0000000000
Actifs Incorporels$47000$27000$382000$772000$347000$330000$271000$212000$49000$2000
Actifs Totaux$184.1M$144.4M$155.2M$104.9M$187.5M$172.7M$262.3M$198.4M$158.5M$102.1M
Dettes Fournisseurs$1.0M$716000$2.1M$2.0M$2.8M$4.9M$997000$410000$679000$937000
Dette à Court Terme0000000000
Passifs Courants$15.8M$14.1M$36.9M$28.6M$57.7M$46.9M$17.3M$14.4M$10.8M$11.0M
Dette à Long Terme0000000000
Passifs Totaux$48.3M$27.7M$63.5M$50.8M$80.3M$65.4M$27.1M$21.9M$16.9M$21.8M
Réserves-$37.3M-$60.7M-$89.9M-$130.9M-$195.2M-$250.9M-$127.8M-$191.8M-$246.3M-$311.8M
Capitaux Propres$135.8M$116.7M$91.7M$54.1M$107.2M$107.3M$235.2M$176.4M$141.6M$80.3M
Dette Totale000$2.5M$7.2M$6.0M$4.8M$3.7M$2.4M$3.6M
Dette Nette-$180.2M-$141.1M-$99.0M-$92.5M-$166.5M-$126.8M-$244.3M-$183.2M-$147.0M-$89.4M
Fonds de Roulement$165.8M$128.4M$116.5M$71.3M$120.1M$117.3M$237.5M$178.0M$143.5M$85.8M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$82.4M$82.7M$64.3M$67.7M
Actifs Totaux$112.2M$102.1M$87.4M$75.4M
Passifs Totaux$16.6M$21.8M$19.1M$17.1M
Capitaux Propres$95.5M$80.3M$68.2M$58.3M
Dette Totale$1.5M$3.6M$3.3M$3.0M

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$18.6M-$25.4M-$37.0M-$36.3M-$62.8M-$63.8M$117.9M-$62.0M-$54.0M-$61.7M
Amortissements$1.1M$1.1M$924000$2.5M$2.9M$2.6M$2.4M$2.4M$2.4M$2.1M
Stock-based Compensation$2.9M$3.6M$3.7M$2.4M$2.9M$4.1M$5.1M$5.2M$4.1M$4.4M
Variation du BFR$1.2M-$217000$131000$30.2M$22.5M-$34.7M-$6.0M-$6.0M-$3.8M$1.2M
Cash Flow Opérationnel-$35.4M-$40.0M-$42.5M-$1.2M-$29.0M-$91.0M$118.6M-$59.0M-$59.2M-$51.3M
CapEx-$1.1M-$500000-$867000-$1.9M-$1.7M-$1.3M-$1.4M-$575000-$723000-$714000
Acquisitions0-$19000-$411000$833000$232000$3740000000
Rachat d'Actions000000-$631000000
Dividendes Payés0000000000
Free Cash Flow-$36.5M-$40.5M-$43.3M-$3.1M-$30.7M-$92.3M$117.1M-$59.8M-$60.0M-$52.0M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$12.8M-$13.5M-$14.5M-$10.8M
CapEx-$63127-$1744240-$20459
Free Cash Flow-$12.8M-$13.6M-$14.5M-$10.8M
Dividendes Payés0000
Stock-based Compensation$1.1M$973000$9360000

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)-13.1%-48.3%+96.8%-54.2%-0.1%+1931.7%-96.3%-29.4%-100.0%
Croissance Résultat Net (annuelle)-36.6%-45.6%+2.0%-73.0%-1.6%+284.8%-152.6%+12.8%-14.1%
Croissance BPA (annuelle)-34.1%-43.4%+3.4%-48.5%+17.9%+276.2%-152.1%+15.9%-3.8%
Variation Actions (annuelle)+2.1%+1.5%+1.2%+16.8%+24.0%+7.3%-1.5%+3.9%+9.5%
Croissance FCF (annuelle)-11.1%-7.0%+93.0%-904.5%-200.9%+227.0%-151.1%-0.3%+13.3%
Marge Brute36.8%11.0%-50.7%-113.4%-500.1%-497.2%73.2%-579.8%-855.8%
Marge Opérationnelle-84.6%-129.1%-361.3%-179.9%-624.2%-679.7%61.5%-868.3%-1231.7%
Marge EBITDA-76.1%-123.4%-348.7%-165.3%-637.7%-650.2%62.8%-845.6%-1039.2%
Marge Nette-80.8%-127.0%-357.7%-178.0%-671.7%-683.7%62.2%-880.7%-1087.4%
Marge FCF-158.3%-202.4%-418.6%-15.0%-328.2%-988.9%61.8%-849.9%-1206.7%
Taux d'Imposition Effectif-0.0%0.0%0.4%-0.0%0.0%-0.0%0.0%-0.0%-0.0%-0.0%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-1.79$-1.94$-2.05$-0.14$-1.23$-2.98$3.52$-1.83$-1.76$-1.39
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$20.4M$20.9M$21.2M$21.4M$25.0M$31.0M$32.5M$32.8M$34.0M$37.3M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres-67.67%
Rentabilité du capital investi-76.91%
Rentabilité des actifs-67.68%
Marge brute0.00%
Marge opérationnelle0.00%
Marge nette0.00%

Santé financière

Dette / Capitaux propres0.05
Ratio de liquidité7.27

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-21.97-15.68-11.05-11.25-6.93-8.491.67-1.86-2.71-2.10
P/B3.013.424.467.524.065.050.840.651.041.60
P/V17.7319.9439.5219.9646.5658.111.0416.3629.530.00
Marge Brute36.8%11.0%-50.7%-113.4%-500.1%-497.2%73.2%-579.8%-855.8%0.0%
Marge Opérationnelle-84.6%-129.1%-361.3%-179.9%-624.2%-679.7%61.5%-868.3%-1231.7%0.0%
Marge Nette-80.8%-127.0%-357.7%-178.0%-671.7%-683.7%62.2%-880.7%-1087.4%0.0%

Entreprises liées: ALEC · APLT · CRBP · CRDF · ELTX · MIST · NKTX

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de MOLN: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions